[Update drug therapy of juvenile rheumatoid arthritis]

Effect of slow release nifedipine tablets in patients with essential hypertension.

Arzneimittel-Forschung·1992

The 11q- syndrome with mosaic partial deletion of 11q.

Acta paediatrica Japonica : Overseas edition·1992

[Seasonal fluctuations of substance P and vasoactive intestinal peptide concentrations in nasal secretions of patients with nasal allergy to Japanese cedar pollen].

Arerugi = [Allergy]·1992

Endogenous tumor necrosis factor functions as a resistant factor against hyperthermic cytotoxicity.

Cancer research·1992

Comparative in-vitro activities of newer cephalosporins cefclidin, cefepime, and cefpirome against ceftazidime- or imipenem-resistant Pseudomonas aeruginosa.

The Journal of antimicrobial chemotherapy·1992

Tumor cytostasis mediated by LPS- or PSK-activated human plastic-adherent peripheral blood mononuclear cells.

Cellular immunology·1992

[Successfully treated case with microscopic polyangiitis complicated severe varicella zoster virus infection including encephalitis and disseminated varicella zoster].

Ryumachi. [Rheumatism]·2003

[Hemophagocytic syndrome associated with hypercytokinemia in a patients with rheumatoid arthritis].

Ryumachi. [Rheumatism]·2003

[Case of systemic sclerosis presenting with alveolar hemorrhage and positive anti-neutrophil cytoplasmic myeloperoxidase antibody(MPO-ANCA) without pathological renal involvement].

Ryumachi. [Rheumatism]·2003

[Case of vascular Behçet's disease initially presented with Bürger's disease-like vasculitides].

Ryumachi. [Rheumatism]·2003

[A case of Poncet's disease (tuberculous rheumatism) in a patient with chronic renal failure undergoing hemodialysis therapy].

Ryumachi. [Rheumatism]·2003

[A case of psoriatic arthropathy complicated with HTLV-I carrier and secondary amyloidosis].

Ryumachi. [Rheumatism]·2003

[Buprenorphine and pain management: Clinical insights and practical landmarks].

Therapie·2026

Clinical Physiology of SGLT2 Inhibitors in Non-diabetic and Diabetic Individuals.

Handbook of experimental pharmacology·2026

Must RAAS-modifying drugs be withdrawn for the diagnosis of primary aldosteronism?

The Journal of clinical endocrinology and metabolism·2026

Phosphate storm in chronic kidney disease-mineral and bone disorder: practical clinical strategies for vascular calcification control.

Nephron·2026

Combination Treatment of IL-17 Inhibitor and JAK Inhibitor in Psoriatic Arthritis: A Case Report and Scoping Review.

Immunity, inflammation and disease·2026

Intranasal midazolam vs mouth-dissolving clobazam in terminating seizures: A randomized controlled trial.

Epilepsia·2026

Related Experiment Videos

[Update drug therapy of juvenile rheumatoid arthritis]

Related Concept Videos

Effect of slow release nifedipine tablets in patients with essential hypertension.

The 11q- syndrome with mosaic partial deletion of 11q.

[Seasonal fluctuations of substance P and vasoactive intestinal peptide concentrations in nasal secretions of patients with nasal allergy to Japanese cedar pollen].

Endogenous tumor necrosis factor functions as a resistant factor against hyperthermic cytotoxicity.

Comparative in-vitro activities of newer cephalosporins cefclidin, cefepime, and cefpirome against ceftazidime- or imipenem-resistant Pseudomonas aeruginosa.

Tumor cytostasis mediated by LPS- or PSK-activated human plastic-adherent peripheral blood mononuclear cells.

[Successfully treated case with microscopic polyangiitis complicated severe varicella zoster virus infection including encephalitis and disseminated varicella zoster].

[Hemophagocytic syndrome associated with hypercytokinemia in a patients with rheumatoid arthritis].

[Case of systemic sclerosis presenting with alveolar hemorrhage and positive anti-neutrophil cytoplasmic myeloperoxidase antibody(MPO-ANCA) without pathological renal involvement].

[Case of vascular Behçet's disease initially presented with Bürger's disease-like vasculitides].

[A case of Poncet's disease (tuberculous rheumatism) in a patient with chronic renal failure undergoing hemodialysis therapy].

[A case of psoriatic arthropathy complicated with HTLV-I carrier and secondary amyloidosis].

[Buprenorphine and pain management: Clinical insights and practical landmarks].

Clinical Physiology of SGLT2 Inhibitors in Non-diabetic and Diabetic Individuals.

Must RAAS-modifying drugs be withdrawn for the diagnosis of primary aldosteronism?

Phosphate storm in chronic kidney disease-mineral and bone disorder: practical clinical strategies for vascular calcification control.

Combination Treatment of IL-17 Inhibitor and JAK Inhibitor in Psoriatic Arthritis: A Case Report and Scoping Review.

Intranasal midazolam vs mouth-dissolving clobazam in terminating seizures: A randomized controlled trial.

Related Experiment Videos

[Update drug therapy of juvenile rheumatoid arthritis]

Related Concept Videos

Related Articles